BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 24092747)

  • 1. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
    Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.
    Kontush A; Therond P; Zerrad A; Couturier M; Négre-Salvayre A; de Souza JA; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1843-9. PubMed ID: 17569880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.
    Rached F; Lhomme M; Camont L; Gomes F; Dauteuille C; Robillard P; Santos RD; Lesnik P; Serrano CV; Chapman MJ; Kontush A
    Biochim Biophys Acta; 2015 Sep; 1851(9):1254-61. PubMed ID: 26037829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel liquid chromatography-mass spectrometrymethod to analyze hdl lipidome.
    Patol Fiziol Eksp Ter; 2016; 60(3):95-100. PubMed ID: 29244914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.
    Rached F; Santos RD; Camont L; Miname MH; Lhomme M; Dauteuille C; Lecocq S; Serrano CV; Chapman MJ; Kontush A
    J Lipid Res; 2014 Dec; 55(12):2509-20. PubMed ID: 25341944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
    Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
    Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.
    Denimal D; Pais de Barros JP; Petit JM; Bouillet B; Vergès B; Duvillard L
    Atherosclerosis; 2015 Aug; 241(2):752-60. PubMed ID: 26142685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation.
    Gómez Rosso L; Lhomme M; Meroño T; Sorroche P; Catoggio L; Soriano E; Saucedo C; Malah V; Dauteuille C; Boero L; Lesnik P; Robillard P; John Chapman M; Brites F; Kontush A
    Atherosclerosis; 2014 Dec; 237(2):652-60. PubMed ID: 25463101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency.
    Zakiev E; Rached F; Lhomme M; Darabi-Amin M; Ponnaiah M; Becker PH; Therond P; Serrano CV; Santos RD; Chapman MJ; Orekhov A; Kontush A
    J Clin Lipidol; 2019; 13(3):468-480.e8. PubMed ID: 31003938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations.
    Ponnaiah M; Zakiev E; Lhomme M; Rached F; Camont L; Serrano CV; Santos RD; Chapman MJ; Orekhov A; Kontush A
    Atheroscler Plus; 2024 Mar; 55():21-30. PubMed ID: 38226021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.
    Kontush A; Chapman MJ
    Curr Opin Lipidol; 2010 Aug; 21(4):312-8. PubMed ID: 20581677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
    de Souza JA; Vindis C; Hansel B; Nègre-Salvayre A; Therond P; Serrano CV; Chantepie S; Salvayre R; Bruckert E; Chapman MJ; Kontush A
    Atherosclerosis; 2008 Mar; 197(1):84-94. PubMed ID: 17868679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
    Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
    J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of hypochlorite in the modification of high density lipoproteins.
    Pirillo A; Uboldi P; Catapano AL
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):447-51. PubMed ID: 21094143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density lipoprotein 3 inhibits oxidized low density lipoprotein-induced apoptosis via promoting cholesterol efflux in RAW264.7 cells.
    Jiang P; Yan PK; Chen JX; Zhu BY; Lei XY; Yin WD; Liao DF
    Acta Pharmacol Sin; 2006 Feb; 27(2):151-7. PubMed ID: 16412263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux.
    Pirillo A; Uboldi P; Pappalardo G; Kuhn H; Catapano AL
    Cardiovasc Res; 2007 Aug; 75(3):566-74. PubMed ID: 17524375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
    Kontush A; Chapman MJ
    Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.